• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
MyomiRNAs Dysregulation in ALS Rehabilitation.肌萎缩侧索硬化症康复中肌微小RNA的失调
Brain Sci. 2019 Jan 10;9(1):8. doi: 10.3390/brainsci9010008.
2
MicroRNAs and HDAC4 protein expression in the skeletal muscle of ALS patients.肌萎缩侧索硬化症患者骨骼肌中的 microRNAs 和 HDAC4 蛋白表达。
Clin Neuropathol. 2020 May/Jun;39(3):105-114. doi: 10.5414/NP301233.
3
MyomiRs and their multifaceted regulatory roles in muscle homeostasis and amyotrophic lateral sclerosis.肌微小 RNA 及其在肌肉动态平衡和肌萎缩性侧索硬化症中的复杂调控作用。
J Cell Sci. 2021 Jun 15;134(12). doi: 10.1242/jcs.258349. Epub 2021 Jun 17.
4
Circulating myomiRs in Muscle Denervation: From Surgical to ALS Pathological Condition.肌源性循环微小 RNA 在肌肉失神经支配中的变化:从外科手术到 ALS 病理状况。
Cells. 2021 Aug 10;10(8):2043. doi: 10.3390/cells10082043.
5
MyomiRNAs and myostatin as physical rehabilitation biomarkers for myotonic dystrophy.肌微RNA和肌生成抑制素作为强直性肌营养不良的物理康复生物标志物。
Neurol Sci. 2020 Oct;41(10):2953-2960. doi: 10.1007/s10072-020-04409-2. Epub 2020 Apr 29.
6
Skeletal Muscle Satellite Cells, Mitochondria, and MicroRNAs: Their Involvement in the Pathogenesis of ALS.骨骼肌卫星细胞、线粒体与微小RNA:它们在肌萎缩侧索硬化症发病机制中的作用
Front Physiol. 2016 Sep 13;7:403. doi: 10.3389/fphys.2016.00403. eCollection 2016.
7
Circulating MyomiRs as Potential Biomarkers to Monitor Response to Nusinersen in Pediatric SMA Patients.循环肌微RNA作为监测小儿脊髓性肌萎缩症患者对诺西那生钠反应的潜在生物标志物
Biomedicines. 2020 Jan 26;8(2):21. doi: 10.3390/biomedicines8020021.
8
Differential expression of microRNAs and other small RNAs in muscle tissue of patients with ALS and healthy age-matched controls.肌组织中 ALS 患者与年龄匹配健康对照者微小 RNA 和其他小 RNA 的差异表达。
Sci Rep. 2018 Apr 4;8(1):5609. doi: 10.1038/s41598-018-23139-2.
9
Identification of a circulating miRNA signature in extracellular vesicles collected from amyotrophic lateral sclerosis patients.从肌萎缩侧索硬化症患者的细胞外囊泡中鉴定出循环 miRNA 特征。
Brain Res. 2019 Apr 1;1708:100-108. doi: 10.1016/j.brainres.2018.12.016. Epub 2018 Dec 12.
10
MicroRNA Profiling Reveals Marker of Motor Neuron Disease in ALS Models.微小RNA分析揭示肌萎缩侧索硬化症模型中运动神经元疾病的标志物。
J Neurosci. 2017 May 31;37(22):5574-5586. doi: 10.1523/JNEUROSCI.3582-16.2017. Epub 2017 Apr 17.

引用本文的文献

1
A Review of Biomarkers of Amyotrophic Lateral Sclerosis: A Pathophysiologic Approach.肌萎缩侧索硬化症生物标志物的研究进展:病理生理学方法。
Int J Mol Sci. 2024 Oct 10;25(20):10900. doi: 10.3390/ijms252010900.
2
Efficacy of non-pharmacological interventions for individuals with amyotrophic lateral sclerosis: systematic review and network meta-analysis of randomized control trials.非药物干预对肌萎缩侧索硬化症患者的疗效:随机对照试验的系统评价和网络荟萃分析。
Sci Rep. 2024 May 18;14(1):11365. doi: 10.1038/s41598-024-62213-w.
3
MicroRNA as potential biomarker for severity, progression, and therapeutic monitoring in animal models of limb-girdle muscular dystrophy: a systematic review.

本文引用的文献

1
Circulating miRNAs as Diagnostic Biomarkers for Parkinson's Disease.循环微小RNA作为帕金森病的诊断生物标志物
Front Neurosci. 2018 Sep 5;12:625. doi: 10.3389/fnins.2018.00625. eCollection 2018.
2
Macro roles for microRNAs in neurodegenerative diseases.微小RNA在神经退行性疾病中的宏观作用
Noncoding RNA Res. 2018 Jul 31;3(3):154-159. doi: 10.1016/j.ncrna.2018.07.001. eCollection 2018 Sep.
3
Stage of prolonged survival in ALS.肌萎缩侧索硬化症的长期存活阶段
微小RNA作为肢带型肌营养不良动物模型中严重程度、疾病进展及治疗监测的潜在生物标志物:一项系统综述
Front Cell Neurosci. 2023 Dec 7;17:1233181. doi: 10.3389/fncel.2023.1233181. eCollection 2023.
4
High-mobility group box-1 impedes skeletal muscle regeneration via downregulation of Pax-7 synthesis by increasing miR-342-5p expression.高迁移率族蛋白 B1 通过增加 miR-342-5p 的表达抑制 Pax-7 的合成从而阻碍骨骼肌再生。
Aging (Albany NY). 2023 Nov 13;15(21):12618-12632. doi: 10.18632/aging.205202.
5
A meta-analysis of post-exercise outcomes in people with amyotrophic lateral sclerosis.肌萎缩侧索硬化症患者运动后结果的荟萃分析。
eNeurologicalSci. 2023 Feb 21;31:100452. doi: 10.1016/j.ensci.2023.100452. eCollection 2023 Jun.
6
Clinical Trials of Non-Coding RNAs as Diagnostic and Therapeutic Biomarkers for Central Nervous System Injuries.非编码RNA作为中枢神经系统损伤诊断和治疗生物标志物的临床试验
Curr Neuropharmacol. 2023;21(11):2237-2246. doi: 10.2174/1570159X21666221128090025.
7
Epigenetic Alterations in Sports-Related Injuries.运动相关性损伤中的表观遗传学改变。
Genes (Basel). 2022 Aug 17;13(8):1471. doi: 10.3390/genes13081471.
8
Mixed Comparison of Different Exercise Interventions for Function, Respiratory, Fatigue, and Quality of Life in Adults With Amyotrophic Lateral Sclerosis: Systematic Review and Network Meta-Analysis.肌萎缩侧索硬化症成人患者不同运动干预对功能、呼吸、疲劳及生活质量影响的混合比较:系统评价与网状Meta分析
Front Aging Neurosci. 2022 Jul 11;14:919059. doi: 10.3389/fnagi.2022.919059. eCollection 2022.
9
Opportunities Offered by Graphene Nanoparticles for MicroRNAs Delivery for Amyotrophic Lateral Sclerosis Treatment.石墨烯纳米颗粒为肌萎缩侧索硬化症治疗递送微小核糖核酸提供的机遇
Materials (Basel). 2021 Dec 24;15(1):126. doi: 10.3390/ma15010126.
10
RNA Deregulation in Amyotrophic Lateral Sclerosis: The Noncoding Perspective.RNA 失调在肌萎缩侧索硬化症中的作用:非编码视角。
Int J Mol Sci. 2021 Sep 24;22(19):10285. doi: 10.3390/ijms221910285.
Lancet Neurol. 2018 Jul;17(7):579. doi: 10.1016/S1474-4422(18)30207-2.
4
Skeletal Muscle MicroRNAs as Key Players in the Pathogenesis of Amyotrophic Lateral Sclerosis.骨骼肌 microRNAs 在肌萎缩侧索硬化症发病机制中的关键作用。
Int J Mol Sci. 2018 May 22;19(5):1534. doi: 10.3390/ijms19051534.
5
Effects of combined endurance and resistance training in Amyotrophic Lateral Sclerosis: A pilot, randomized, controlled study.耐力与抗阻训练相结合对肌萎缩侧索硬化症的影响:一项前瞻性、随机、对照研究。
Eur J Transl Myol. 2018 Mar 23;28(1):7278. doi: 10.4081/ejtm.2018.7278. eCollection 2018 Jan 12.
6
New insights into the gene expression associated to amyotrophic lateral sclerosis.肌萎缩侧索硬化症相关基因表达的新见解。
Life Sci. 2018 Jan 15;193:110-123. doi: 10.1016/j.lfs.2017.12.016. Epub 2017 Dec 11.
7
A randomized controlled trial of resistance and endurance exercise in amyotrophic lateral sclerosis.肌萎缩侧索硬化症中抗阻运动与耐力运动的随机对照试验
Amyotroph Lateral Scler Frontotemporal Degener. 2018 May;19(3-4):250-258. doi: 10.1080/21678421.2017.1404108. Epub 2017 Nov 30.
8
Micro-RNAs in ALS muscle: Differences in gender, age at onset and disease duration.肌萎缩侧索硬化症肌肉中的 micro-RNAs:性别、发病年龄和疾病持续时间的差异。
J Neurol Sci. 2017 Sep 15;380:58-63. doi: 10.1016/j.jns.2017.07.008. Epub 2017 Jul 6.
9
Amyotrophic Lateral Sclerosis.肌萎缩侧索硬化症
N Engl J Med. 2017 Jul 13;377(2):162-172. doi: 10.1056/NEJMra1603471.
10
Decoding ALS: from genes to mechanism.解码肌萎缩侧索硬化症:从基因到机制
Nature. 2016 Nov 10;539(7628):197-206. doi: 10.1038/nature20413.

肌萎缩侧索硬化症康复中肌微小RNA的失调

MyomiRNAs Dysregulation in ALS Rehabilitation.

作者信息

Pegoraro Valentina, Merico Antonio, Angelini Corrado

机构信息

Fondazione Ospedale San Camillo IRCCS, via Alberoni 70, 30126 Venezia, Italy.

出版信息

Brain Sci. 2019 Jan 10;9(1):8. doi: 10.3390/brainsci9010008.

DOI:10.3390/brainsci9010008
PMID:30634563
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6356197/
Abstract

Amyotrophic lateral sclerosis (ALS) is a rare, progressive, neurodegenerative disorder caused by degeneration of upper and lower motor neurons. The disease process leads, because of lower motor neuron involvement, to progressive muscle atrophy, weakness, and fasciculations and for the upper motor neuron involvement leads to spasticity. Muscle atrophy in ALS is caused by a neural dysregulation in the molecular network controlling fast and slow muscle fibers. Denervation and reinnervation processes in skeletal muscle occur in the course of ALS and are modulated by rehabilitation. MicroRNAs (miRNAs) are small, non-coding RNAs that are involved in different biological functions under various pathophysiological conditions. MiRNAs can be secreted by various cell types and they are markedly stable in body fluids. MiR-1, miR-133 a miR-133b, and miR-206 are called "myomiRs" and are considered markers of myogenesis during muscle regeneration and contribute to neuromuscular junction stabilization or sprouting. We observed a positive effect of a standard aerobic exercise rehabilitative protocol conducted for six weeks in 18 ALS patients during hospitalization in our center. This is a preliminary study, in which we correlated clinical scales with molecular data on myomiRs. After six weeks of moderate aerobic exercise, we found lower levels in serum of myomiRNAs. Our data suggest that circulating miRNAs changed during skeletal muscle recovery in response to physical rehabilitation in ALS. However, no firm conclusions can be made on the ALS-specific effect of exercise on miRNA levels.

摘要

肌萎缩侧索硬化症(ALS)是一种罕见的、进行性的神经退行性疾病,由上、下运动神经元变性引起。由于下运动神经元受累,疾病进程导致进行性肌肉萎缩、无力和肌束震颤,而上运动神经元受累则导致痉挛。ALS中的肌肉萎缩是由控制快、慢肌纤维的分子网络中的神经调节异常引起的。骨骼肌的去神经和再支配过程在ALS病程中发生,并受康复治疗的调节。微小RNA(miRNA)是小的非编码RNA,在各种病理生理条件下参与不同的生物学功能。miRNA可由多种细胞类型分泌,并且在体液中显著稳定。miR-1、miR-133a、miR-133b和miR-206被称为“肌源miRNA”,被认为是肌肉再生过程中肌生成的标志物,并有助于神经肌肉接头的稳定或发芽。我们观察到在我们中心住院期间,对18例ALS患者进行为期六周的标准有氧运动康复方案产生了积极效果。这是一项初步研究,我们将临床量表与肌源miRNA的分子数据进行了关联。经过六周的中等强度有氧运动后,我们发现血清中肌源miRNA水平降低。我们的数据表明,在ALS患者中,循环miRNA在骨骼肌恢复过程中因身体康复而发生变化。然而,关于运动对miRNA水平的ALS特异性影响,目前还不能得出确凿的结论。